The current price of GMED is $81.14 — it has decreased by 6.84% since the previous close. Data as of Nov 5, 2026.
GMED is up 0.42% over the past week, up 5.97% over the past month and up 31.91% over the past year. The price is below its 200-day moving average of $83.33.
Analysts' average 12-month price target for GMED is $95.13, which implies 17.24% upside from the current price. Individual estimates range from $80.00 to $117.00.
Of the 14 analysts covering Globus Medical, Inc., 3 rate it a strong buy, 7 rate it a buy and 4 rate it a hold. The overall consensus is bullish. Analyst ratings are opinions and do not guarantee future performance.
Globus Medical, Inc. has a market capitalization of $10.89B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Globus Medical, Inc. posted earnings of $1.34 per share against an estimate of $1.10, beating expectations by 21.82%. Upcoming reports are listed in the earnings calendar.
Globus Medical, Inc. reported revenue of $789.61M in its most recent quarter, which has increased by 5.94% compared with the same quarter a year earlier. Analysts had expected $782.88M.
Globus Medical, Inc. has not paid any dividends over the past year.
Companies most comparable to Globus Medical, Inc. include Stryker Corporation, Zimmer Biomet Holdings, Inc., Smith & Nephew plc, Alphatec Holdings, Inc. and SI-BONE, Inc.
In the latest trading session GMED moved between $81.00 and $88.10, a range of 8.75% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Globus Medical, Inc. shows a buy rating today and a buy rating on the weekly timeframe. Market conditions change quickly, so it is worth looking further ahead as well — the 1-month rating for Globus Medical, Inc. is buy. Technical ratings are indicators, not investment advice.
Over the past 52 weeks GMED has traded between $60.36 and $101.40. The current price is 19.98% below its 52-week high.
Figures as of Nov 5, 2026. This information is provided for general purposes only and is not investment advice.